RedHill Biopharma (RDHL) Interest Coverage Ratio (2012 - 2023)
RedHill Biopharma's (RDHL) quarterly Interest Coverage Ratio came in at 27.91 in Q2 2023, up 1184.06% year-over-year from 2.17 in Q2 2022, and up 140.4% quarter-over-quarter from 69.07 in Q1 2023.
Powered by 
Analysis
RedHill Biopharma (RDHL) Interest Coverage Ratio (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Interest Coverage Ratio for 12 consecutive years, with 27.91 the latest figure, recorded in Q2 2023.
- On a quarterly basis, Interest Coverage Ratio rose 1184.06% year-over-year to 27.91 in Q2 2023; TTM through Jun 2023 was 1.2, a 80.7% increase from a year earlier, with the FY2025 full-year figure at 5.45, down 27.37% from the prior year.
- Interest Coverage Ratio was 27.91 for Q2 2023 at RedHill Biopharma, up from 69.07 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 167.3 in Q2 2019 and troughed at 69.07 in Q1 2023.
- A 5-year average of 14.99 and a median of 4.25 in 2020 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio jumped 2905.64% in 2019 and tumbled 1723.72% in 2023, its largest moves.
- Over 5 years, Interest Coverage Ratio stood at 62.91 in 2019, then sank by 93.25% to 4.24 in 2020, then sank by 1004.85% to 38.41 in 2021, then increased by 20.52% to 30.53 in 2022, then surged by 191.42% to 27.91 in 2023.
- The last three Interest Coverage Ratio figures came in at 27.91 (Q2 2023), 69.07 (Q1 2023), and 30.53 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 27.91 |
| Mar 31, 2023 | -69.07 |
| Dec 31, 2022 | -30.53 |
| Sep 30, 2022 | 0.22 |
| Jun 30, 2022 | 2.17 |
| Mar 31, 2022 | 4.25 |
| Dec 31, 2021 | -38.41 |
| Sep 30, 2021 | 4.34 |
| Jun 30, 2021 | 5.86 |
| Mar 31, 2021 | 3.82 |
| Dec 31, 2020 | 4.24 |
| Sep 30, 2020 | 3.43 |
| Jun 30, 2020 | 3.42 |
| Mar 31, 2020 | 47.93 |
| Dec 31, 2019 | 62.91 |
| Sep 30, 2019 | 61.14 |
| Jun 30, 2019 | 167.30 |
| Mar 31, 2019 | 8.94 |
| Dec 31, 2018 | 228.25 |
| Sep 30, 2018 | 20.28 |